Vaxcyte's GAAP loss for 3 months of 2022 was $38.986 million, up 83.7% from $21.22 million in the previous year.
Vaxcyte's GAAP loss for 3 months of 2022 was $38.986 million, up 83.7% from $21.22 million in the previous year.
Vaxcyte reported for 3 months of 2022
Vaxcyte's GAAP loss for 3 months of 2022 was $38.986 million, up 83.7% from $21.22 million in the previous year. Source: 
investors.vaxcyte.com
investors.vaxcyte.com
English (US) 